Skip to main content
Journal cover image

Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study

Publication ,  Conference
Januzzi, JL; Prescott, MF; Butler, J; Felker, M; Maisel, AS; Pina, I; Shah, A; Rocha, R; Williamson, K; Solomon, S
Published in: Journal of Cardiac Failure
November 2019

Duke Scholars

Published In

Journal of Cardiac Failure

DOI

ISSN

1071-9164

Publication Date

November 2019

Volume

25

Issue

11

Start / End Page

937 / 937

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1110 Nursing
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Januzzi, J. L., Prescott, M. F., Butler, J., Felker, M., Maisel, A. S., Pina, I., … Solomon, S. (2019). Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study. In Journal of Cardiac Failure (Vol. 25, pp. 937–937). Elsevier BV. https://doi.org/10.1016/j.cardfail.2019.11.004
Januzzi, James L., Margaret F. Prescott, Javed Butler, Michael Felker, Alan S. Maisel, Ileana Pina, Amil Shah, Ricardo Rocha, Kristin Williamson, and Scott Solomon. “Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study.” In Journal of Cardiac Failure, 25:937–937. Elsevier BV, 2019. https://doi.org/10.1016/j.cardfail.2019.11.004.
Januzzi JL, Prescott MF, Butler J, Felker M, Maisel AS, Pina I, et al. Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study. In: Journal of Cardiac Failure. Elsevier BV; 2019. p. 937–937.
Januzzi, James L., et al. “Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study.” Journal of Cardiac Failure, vol. 25, no. 11, Elsevier BV, 2019, pp. 937–937. Crossref, doi:10.1016/j.cardfail.2019.11.004.
Januzzi JL, Prescott MF, Butler J, Felker M, Maisel AS, Pina I, Shah A, Rocha R, Williamson K, Solomon S. Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study. Journal of Cardiac Failure. Elsevier BV; 2019. p. 937–937.
Journal cover image

Published In

Journal of Cardiac Failure

DOI

ISSN

1071-9164

Publication Date

November 2019

Volume

25

Issue

11

Start / End Page

937 / 937

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1110 Nursing
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology